Unassigned Industry (102) | Collaboration Agreements (447)
Browse by Company
-
4D Molecular Therapeutics Inc (3)
-
AbCellera Biologics Inc. (1)
-
Acumen Pharmaceuticals, Inc. (1)
-
ALLEGRO MICROSYSTEMS INC (2)
-
Allovir, Inc. (1)
-
ArcherDX, Inc. (3)
-
Arcturus Therapeutics Ltd. (1)
-
Artiva Biotherapeutics, Inc. (2)
-
ATAI Life Sciences B.V. (1)
-
Berkeley Lights, Inc. (1)
-
BioAtla, Inc. (1)
-
BIODESIX INC (1)
-
C4 Therapeutics, Inc. (2)
-
Century Therapeutics, Inc. (4)
-
Checkmate Pharmaceuticals, Inc. (1)
-
Conatus Pharmaceuticals Inc. (1)
-
Context Therapeutics Inc. (1)
-
Crown Electrokinetics Corp. (1)
-
Cullinan Oncology, LLC (2)
-
Decibel Therapeutics, Inc. (1)
-
Elevation Oncology, Inc. (2)
-
EMPIRE RESORTS INC (1)
-
Foghorn Therapeutics Inc. (1)
-
Forma Therapeutics Holdings, Inc., (1)
-
Forty Seven, Inc. (1)
-
Fusion Pharmaceuticals Inc. (1)
-
GridIron BioNutrients, Inc. (2)
-
IIOT-OXYS, Inc. (1)
-
Ikena Oncology, Inc. (1)
-
iTeos Therapeutics, Inc. (2)
-
Janux Therapeutics, Inc. (1)
-
Kiromic Biopharma, Inc. (2)
-
Kymera Therapeutics, Inc. (3)
-
Locust Walk Acquisition Corp. (1)
-
Lyell Immunopharma, Inc. (2)
-
Monte Rosa Therapeutics, Inc. (1)
-
Morphic Holding, Inc. (8)
-
Nascent Biotech Inc. (1)
-
Nurix Therapeutics, Inc. (3)
-
Olema Pharmaceuticals, Inc. (1)
-
Olivia Ventures, Inc. (1)
-
Pandion Therapeutics Holdco LLC (2)
-
Pasithea Therapeutics Corp. (2)
-
Phoenix Plus Corp. (2)
-
Praxis Precision Medicines, Inc. (1)
-
Prometheus Biosciences, Inc. (1)
-
RECURSION PHARMACEUTICALS, INC. (1)
-
Relay Therapeutics, Inc. (2)
-
Repare Therapeutics Inc. (5)
-
Roivant Sciences Ltd. (1)
-
SERA PROGNOSTICS, INC. (1)
-
Shattuck Labs, Inc. (1)
-
Sigilon Therapeutics, Inc. (1)
-
SQZ Biotechnologies Co (2)
-
TAURIGA SCIENCES, INC. (2)
-
Taysha Gene Therapies, Inc. (2)
-
TScan Therapeutics, Inc. (1)
-
UAS Drone Corp. (1)
-
Vaccitech plc (1)
-
Verve Therapeutics, Inc. (1)
-
Virpax Pharmaceuticals, Inc. (4)
Recent Contracts
-
Collaboration Agreement dated June 14, 2021, between Caris MPI, Inc. and Elevation Oncology, Inc
(Elevation Oncology, Inc., Filed With SEC on June 16, 2021)
-
Research Collaboration and License Agreement, dated December 20, 2019, by and between eFFECTOR and Pfizer Inc
(Locust Walk Acquisition Corp., Filed With SEC on June 14, 2021)
-
Commercial Collaboration Agreement, dated as of February 17, 2021, by and between Anthem, Inc. and the Registrant
(SERA PROGNOSTICS, INC., Filed With SEC on June 11, 2021)
-
Collaboration and License Agreement by and between the Registrant, GlaxoSmithKline Intellectual Property (No. 5) Limited and Glaxo Group Limited, dated May 23, 2019, as amended
(Lyell Immunopharma, Inc., Filed With SEC on June 9, 2021)
-
Collaboration Agreement, by and between the Registrant and Merck & Co., Inc., dated December 22, 2003, as amended and restated as of October 18, 2006
(Acumen Pharmaceuticals, Inc., Filed With SEC on June 9, 2021)
-
Amended and Restated Collaboration Agreement dated January 24, 2007 between Dyax Corp. and Merrimack Pharmaceuticals, Inc., as amended
(Elevation Oncology, Inc., Filed With SEC on June 4, 2021)
-
Collaboration and Option Agreement, dated as of April 10, 2018, among Cancer Research Technology Limited, The Institute of Cancer Research: Royal Cancer Hospital and Monte Rosa...
(Monte Rosa Therapeutics, Inc., Filed With SEC on June 4, 2021)
-
Collaboration and License Agreement, dated as of April 3, 2019, by and between the Registrant and Beam Therapeutics Inc
(Verve Therapeutics, Inc., Filed With SEC on May 28, 2021)
-
Master Collaboration Agreement, by and between Century Therapeutics, Inc. and FUJIFILM Cellular Dynamics, Inc., dated October 21, 2019
(Century Therapeutics, Inc., Filed With SEC on May 28, 2021)
-
Amendment No. 1 to Master Collaboration Agreement, by and between Century Therapeutics, Inc. and FUJIFILM Cellular Dynamics, Inc., dated July 17, 2020
(Century Therapeutics, Inc., Filed With SEC on May 28, 2021)
